The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained ...

NeuroVISION was the study that put perioperative covert strokes on the map in 2019. That report found a 7% rate of these ...

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for ...

Thinking of calling CDC to report a potential disease outbreak? Don't bother; no one will answer, a former CDC employee said ...

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...

The shutdown could become the longest in history, House Speaker Mike Johnson (R-La.) indicated, saying he "won't negotiate" ...

A high proportion of time spent in medication-induced deep sedation in the ICU was associated with an increased risk of loss ...

In a small pivotal trial of an investigational gene therapy, most cases of congenital profound deafness from genetic variants ...

Eric Rafla-Yuan, MD, a psychiatrist and the chair of the Committee to Protect Public Mental Health, said staff cuts at SAMHSA ...

MedPage Today brought together three hepatology experts for a virtual roundtable discussion on metabolic ...

The results also highlight the fact that one shot may still be better than none. Having at least one dose prevented an ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...